AI Articles and Analysis about Customer analytics

Contact centers play a crucial role in delivering exceptional customer experiences (CX) across industries, both B2c and B2b. As customer expectations elevate, organizations increasingly leverage AI to streamline operations and enhance customer service. According to recent reporting in the MIT Technology Review, enterprises generally deploy AI to transform contact centers, usually taking the form of intelligent virtual assistants to obtain predictive customer insights as well as for dispute and fraud management. 

As stakeholders in the life sciences and healthcare industries rush to adopt GenAI and integrate it into their projects and processes, they are walking a tightrope. GenAI will play a vital role in the future of healthcare in ways that we can hardly yet imagine; on the other hand, concerns like patient data privacy and potential inaccuracies have led many to take a cautious approach. 

Capital One, founded in 1994 and headquartered in McLean, Virginia, has become a prominent player in the financial services sector, mainly known for its credit card offerings, auto loans, banking, and savings accounts. With operations primarily spanning the United States, the company boasts a workforce of approximately 52,000 employees. As a technology-focused financial institution, Capital One is dedicated to leveraging cutting-edge innovations to enhance customer experience and streamline operations.

As a rule, AI adoption tends to take more time for legacy industries compared to digitally-native sectors. As a profile from June 2021 in Harvard Business Review explains, insurance companies are data-rich but have long relied on actuarial approaches to data and analytics.  The insurance industry has several concerns regarding the integration of AI. Insurance companies obviously have regulatory compliance as a top priority, so any AI solution implemented needs to comply with existing regulations regarding consumer protection and data security, among others. 

The applications of AI in the healthcare and life sciences industries are vast, with data-powered algorithms and analytics promising to upend the status quo. Applications, including the use of AI to interpret medical imaging, optimize drug discovery and development, analyze large-scale data sets to identify patterns among patient populations, and streamline provider workflows, are already transforming the industry. 

Over the last decade, public introductions of advanced technologies from big tech firms, such as Google Glasses and Meta's (then-Facebook) Metaverse platform, were met with infamous disappointment. In stark contrast, initial iterations of generative AI (GenAI) in large language models and other tools deployed across the global economy by smaller players like OpenAI in the last few years are having a far more lasting impact. A recent report from McKinsey noted that the staying power of GenAI could add $2.6 trillion to 4.4 trillion USD annually to the global economy.

Humana Inc. is the fourth most significant health insurance provider in the U.S. Founded in 1961, Humana is based in Louisville, Kentucky. Humana was ranked 42 on the Fortune 500 list in 2023. Humana employs over 67,000 individuals and is one of the most prominent publicly traded managed care companies in the U.S. 

Far beyond surface-level 'chatbot' software, and other customer-facing support systems, the same generative AI (GenAI) capabilities having direct impacts across language workflows in front-office tasks in financial and legal services is also having a direct impact on how research teams in the life sciences space are targeting solutions for rare diseases and novel treatments.